Last reviewed · How we verify
Esomeprazole Capsule
At a glance
| Generic name | Esomeprazole Capsule |
|---|---|
| Also known as | Nexium, oral, nexium, Esomeprazole Magnesium, Oral Nexium |
| Sponsor | Takeda |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- A Study of Esomeplazole (D961H) in Japanese Paediatric Patients With Reflux Esophagitis, Gastric Ulcer or Duodenal Ulcer (PHASE3)
- Relative Bioavailability of NX-5948 Tablets vs Capsules and the Effect of Covariates on the PK of NX-5948 Tablets (PHASE1)
- Tegoprazan-Amoxicillin Dual Therapy vs. Bismuth Quadruple Therapy for H. Pylori Infection (TATH-1) (PHASE4)
- Drug Interaction Study on Linaprazan Glurate Capsules (PHASE1)
- Safety and PK of Ceftibuten-ledaborbactam Etzadroxil Fixed-dose Combination (PHASE1)
- Saccharomyces Boulardii Combined With Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Treatment (PHASE4)
- A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of INCB160058 When Administered Orally to Healthy Adult Participant (PHASE1)
- Helicobacter Rescue Therapy With Vonorazon and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Esomeprazole Capsule CI brief — competitive landscape report
- Esomeprazole Capsule updates RSS · CI watch RSS
- Takeda portfolio CI